series-a
Stage
2
Investors
About
ReGelTec develops a percutaneous injectable hydrogel implant to treat chronic low back pain caused by degenerative disc disease through a minimally invasive procedure that restores disc function and spinal motion.
Explore ReGelTec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.